Form 4 holding
General Counsel & COO
PMV Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 98,695
- Estimated value
- $105,090
- Report date
- 01 Jul 2025
- Price
- $1.06
- Ownership
- Direct
Robert Ticktin
Insider Reports History
- Location
- Boston, MA
- Owner filing signature
- /s/ Robert Ticktin
- Transaction evidence
- Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
1 identity field
Source record
1 source field
Source evidence
1 source field
Reported holdings for Robert Ticktin
Form 4 holding
General Counsel & COO
PMV Pharmaceuticals, Inc.
- Security class
- Employee Stock Option (right to buy)
- Shares / value
- 319,270
- Estimated value
- Report date
- 05 Mar 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Robert Ticktin
4
PMVP
PMV Pharmaceuticals, Inc.
- Report period
- 05 Mar 2026
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 09 Mar 2026, 16:39
- Role
- General Counsel & COO
- Next action
- Open filing details
4
PMVP
PMV Pharmaceuticals, Inc.
- Report period
- 01 Jul 2025
- Transactions
- 1
- Transaction value
- -$24,651
- Accepted by SEC
- 03 Jul 2025, 19:51
- Role
- General Counsel & COO
- Next action
- Open filing details
3
PMVP
PMV Pharmaceuticals, Inc.
- Report period
- 21 Apr 2025
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 23 Apr 2025, 18:10
- Role
- General Counsel & COO
- Next action
- Open filing details